pharma news today glp-1 obesity drugs Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine π The next trillion-dollar drug
Description
With CVS now covering Lillys obesity medicines, all three major U.S
RM is faculty for Nestle Nutrition Fellowship
Tirzepatide acts as a GIP analog, meaning it mimics the actions of GIP to further improve insulin release
N Engl J Med 377:11191131
Int J Obes (Lond) 2024;48(8):11181125
Third, lifestyle modifications including nutrition counseling and physical activity should be implemented concurrently
